Logo image of ALTO

ALTO INGREDIENTS INC (ALTO) Stock Fundamental Analysis

USA - NASDAQ:ALTO - US0215131063 - Common Stock

0.9172 USD
-0.37 (-28.62%)
Last: 9/19/2025, 8:00:00 PM
1.05 USD
+0.13 (+14.48%)
Pre-Market: 9/22/2025, 4:03:59 AM
Fundamental Rating

2

Taking everything into account, ALTO scores 2 out of 10 in our fundamental rating. ALTO was compared to 83 industry peers in the Chemicals industry. While ALTO seems to be doing ok healthwise, there are quite some concerns on its profitability. ALTO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALTO had negative earnings in the past year.
In the past year ALTO has reported a negative cash flow from operations.
In the past 5 years ALTO reported 4 times negative net income.
Of the past 5 years ALTO 4 years had a positive operating cash flow.
ALTO Yearly Net Income VS EBIT VS OCF VS FCFALTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -17.32%, ALTO is doing worse than 81.93% of the companies in the same industry.
With a Return On Equity value of -32.76%, ALTO is not doing good in the industry: 77.11% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.32%
ROE -32.76%
ROIC N/A
ROA(3y)-10.14%
ROA(5y)-4.95%
ROE(3y)-17.06%
ROE(5y)-8.78%
ROIC(3y)N/A
ROIC(5y)N/A
ALTO Yearly ROA, ROE, ROICALTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

The Gross Margin of ALTO (0.09%) is worse than 91.57% of its industry peers.
ALTO's Gross Margin has declined in the last couple of years.
ALTO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.6%
GM growth 5YN/A
ALTO Yearly Profit, Operating, Gross MarginsALTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 -6

More info and screens

4

2. Health

2.1 Basic Checks

ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALTO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALTO has more shares outstanding
The debt/assets ratio for ALTO is higher compared to a year ago.
ALTO Yearly Shares OutstandingALTO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALTO Yearly Total Debt VS Total AssetsALTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.30, we must say that ALTO is in the distress zone and has some risk of bankruptcy.
ALTO's Altman-Z score of -0.30 is on the low side compared to the rest of the industry. ALTO is outperformed by 85.54% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that ALTO is somewhat dependend on debt financing.
ALTO has a better Debt to Equity ratio (0.57) than 65.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACCN/A
WACC10.27%
ALTO Yearly LT Debt VS Equity VS FCFALTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ALTO has a Current Ratio of 3.52. This indicates that ALTO is financially healthy and has no problem in meeting its short term obligations.
ALTO has a better Current ratio (3.52) than 86.75% of its industry peers.
A Quick Ratio of 2.25 indicates that ALTO has no problem at all paying its short term obligations.
ALTO has a better Quick ratio (2.25) than 81.93% of its industry peers.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 2.25
ALTO Yearly Current Assets VS Current LiabilitesALTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

ALTO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.58%.
The Revenue for ALTO has decreased by -12.69% in the past year. This is quite bad
Measured over the past years, ALTO shows a decrease in Revenue. The Revenue has been decreasing by -7.49% on average per year.
EPS 1Y (TTM)-73.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-12.69%
Revenue growth 3Y-7.2%
Revenue growth 5Y-7.49%
Sales Q2Q%-7.63%

3.2 Future

The Earnings Per Share is expected to grow by 34.90% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALTO will show a quite strong growth in Revenue. The Revenue will grow by 12.23% on average per year.
EPS Next Y50.84%
EPS Next 2Y39.23%
EPS Next 3Y34.9%
EPS Next 5YN/A
Revenue Next Year-3.33%
Revenue Next 2Y1.96%
Revenue Next 3Y12.23%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALTO Yearly Revenue VS EstimatesALTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ALTO Yearly EPS VS EstimatesALTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTO. In the last year negative earnings were reported.
Also next year ALTO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALTO Price Earnings VS Forward Price EarningsALTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTO Per share dataALTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as ALTO's earnings are expected to grow with 34.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.23%
EPS Next 3Y34.9%

More info and screens

0

5. Dividend

5.1 Amount

ALTO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTO INGREDIENTS INC

NASDAQ:ALTO (9/19/2025, 8:00:00 PM)

Premarket: 1.05 +0.13 (+14.48%)

0.9172

-0.37 (-28.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners33.73%
Inst Owner Change-12.81%
Ins Owners4.89%
Ins Owner Change9.14%
Market Cap70.99M
Analysts82.5
Price Target4.08 (344.83%)
Short Float %0.7%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-2.34%
DP-1.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.24%
Min EPS beat(2)-40.06%
Max EPS beat(2)21.57%
EPS beat(4)1
Avg EPS beat(4)-154.12%
Min EPS beat(4)-385.93%
Max EPS beat(4)21.57%
EPS beat(8)2
Avg EPS beat(8)-118.83%
EPS beat(12)3
Avg EPS beat(12)-1084.62%
EPS beat(16)5
Avg EPS beat(16)-815.18%
Revenue beat(2)0
Avg Revenue beat(2)-2.14%
Min Revenue beat(2)-4.23%
Max Revenue beat(2)-0.06%
Revenue beat(4)1
Avg Revenue beat(4)-1.98%
Min Revenue beat(4)-7.73%
Max Revenue beat(4)4.09%
Revenue beat(8)3
Avg Revenue beat(8)-0.87%
Revenue beat(12)6
Avg Revenue beat(12)0.07%
Revenue beat(16)9
Avg Revenue beat(16)1.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.36
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS12.06
BVpS2.69
TBVpS2.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.32%
ROE -32.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.09%
FCFM N/A
ROA(3y)-10.14%
ROA(5y)-4.95%
ROE(3y)-17.06%
ROE(5y)-8.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.6%
GM growth 5YN/A
F-Score2
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.04%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.52
Quick Ratio 2.25
Altman-Z -0.3
F-Score2
WACC10.27%
ROIC/WACCN/A
Cap/Depr(3y)107.88%
Cap/Depr(5y)83.14%
Cap/Sales(3y)2.13%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y50.84%
EPS Next 2Y39.23%
EPS Next 3Y34.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.69%
Revenue growth 3Y-7.2%
Revenue growth 5Y-7.49%
Sales Q2Q%-7.63%
Revenue Next Year-3.33%
Revenue Next 2Y1.96%
Revenue Next 3Y12.23%
Revenue Next 5YN/A
EBIT growth 1Y5.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.6%
EBIT Next 3Y64.22%
EBIT Next 5YN/A
FCF growth 1Y82.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.61%
OCF growth 3YN/A
OCF growth 5YN/A